Saxton, Robert A.
Chantranupong, Lynne
Knockenhauer, Kevin E.
Schwartz, Thomas U.
Sabatini, David M.
Article History
Received: 10 February 2016
Accepted: 5 July 2016
First Online: 3 August 2016
Competing interests
: D.M.S. is a founder and member of the Scientific Advisory Board, a paid consultant, and a shareholder of Navitor Pharmaceuticals, which is targeting for therapeutic benefit the amino-acid-sensing pathway upstream of mTORC1.